Article
Human papillomavirus testing and genotyping in cervical screening.
Expert review of anticancer therapy - 1 Jul 2011
Rebolj Matejka, Lynge Elsebeth, Bonde Jesper
Abstract excerpt
Mass vaccination against human papillomavirus (HPV) genotypes 16 and 18 will, in the long term, reduce the incidence of cervical cancer, but screening will remain an important cancer control measure in both vaccinated and unvaccinated women. Since the 1960s, cytology screening has helped to reduce the incidence of cervical cancer, but has a low sensitivity for high-grade cervical intraepithelial neoplasia (CIN)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
